Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma

المؤلفون المشاركون

Zhang, Qing
Zhang, Haixu
Li, Huizhong
Zheng, Junnian
Tian, Kang
Xu, Jinjing
Li, Liantao
Fu, Qiang
Chai, Dafei

المصدر

Journal of Immunology Research

العدد

المجلد 2017، العدد 2017 (31 ديسمبر/كانون الأول 2017)، ص ص. 1-14، 14ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2017-12-20

دولة النشر

مصر

عدد الصفحات

14

التخصصات الرئيسية

الأحياء

الملخص EN

The chimeric antigen receptor-modified immune effector cell (CAR-T and CAR-NK) therapies are newly developed adoptive treatments of cancers.

However, their therapeutic efficacy against solid tumors is limited.

Combining CAR-T or CAR-NK cells with chemotherapeutic drugs to treat solid tumor may be a promising strategy.

We developed an epidermal growth factor- (EGFR-) specific third-generation CAR.

NK-92 cells were modified with the CAR by lentivirus infection.

The specific killing ability of the CAR-modified NK-92 cells (CAR-NK-92) against renal cell carcinoma (RCC) cell lines was confirmed in vitro.

The synergistic effects of cabozantinib and EGFR-specific CAR-NK-92 cells were investigated in vitro and in vivo.

Our results showed that the CAR-NK-92 cells lyse RCC cells in an EGFR-specific manner.

Treatment with cabozantinib could increase EGFR and decrease PD-L1 membrane surface expression in RCC cells and enhance the killing ability of CAR-NK-92 cells against the RCC cells in vitro.

Furthermore, the CAR-NK-92 cells show synergistic therapeutic efficacy with cabozantinib against human RCC xenograft models.

Our results provided the basis for combination with chemotherapy as a novel strategy for enhancing the therapeutic efficacy of CAR-modified immune effector cells for solid tumors.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Zhang, Qing& Tian, Kang& Xu, Jinjing& Zhang, Haixu& Li, Liantao& Fu, Qiang…[et al.]. 2017. Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma. Journal of Immunology Research،Vol. 2017, no. 2017, pp.1-14.
https://search.emarefa.net/detail/BIM-1182030

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Zhang, Qing…[et al.]. Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma. Journal of Immunology Research No. 2017 (2017), pp.1-14.
https://search.emarefa.net/detail/BIM-1182030

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Zhang, Qing& Tian, Kang& Xu, Jinjing& Zhang, Haixu& Li, Liantao& Fu, Qiang…[et al.]. Synergistic Effects of Cabozantinib and EGFR-Specific CAR-NK-92 Cells in Renal Cell Carcinoma. Journal of Immunology Research. 2017. Vol. 2017, no. 2017, pp.1-14.
https://search.emarefa.net/detail/BIM-1182030

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1182030